Epigenetics of Cardiomyocyte Differentiation

Epigenetic regulation of gene expression is important in determining cell fate and identity, and is a factor in stem cell studies involving cardiomyocyte differentiation. Discover the latest research on Epigenetics in Cardiomyocyte Differentiation here.

September 17, 2021

Inherited Ventricular Arrhythmia in Zebrafish: Genetic Models and Phenotyping Tools.

Reviews of Physiology, Biochemistry and Pharmacology
Ewa SieliwonczykDorien Schepers
September 14, 2021

TFEB Insufficiency Promotes Cardiac Hypertrophy by Blocking Autophagic Degradation of GATA4.

The Journal of Biological Chemistry
Rui SongJie Liu
September 14, 2021

Comparison of the histology and stiffness of ventricles in Anura of different habitats.

Journal of Biological Physics
Megumi ItoMasanori Nakamura
September 14, 2021
Open Access

ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment.

Molecular Therapy. Nucleic Acids
Zhenbo HanBenzhi Cai
September 13, 2021

Delineating chromatin accessibility re-patterning at single cell level during early stage of direct cardiac reprogramming.

Journal of Molecular and Cellular Cardiology
Haofei WangLi Qian
September 10, 2021

Analysis of Clonal Composition in Human iPSC and ESC and Derived 2D and 3D Differentiated Cultures.

Methods in Molecular Biology
Bernat Del OlmoAngels Almenar-Queralt
September 10, 2021

Multiomics Method Enabled by Sequential Metabolomics and Proteomics for Human Pluripotent Stem-Cell-Derived Cardiomyocytes.

Journal of Proteome Research
Elizabeth F BayneYing Ge
September 10, 2021

CHIR99021 Promotes hiPSC-Derived Cardiomyocyte Proliferation in Engineered 3D Microtissues.

Advanced Healthcare Materials
Ramona HesselbarthFelix B Engel
September 8, 2021

Histone deacetylase 4 deletion broadly affects cardiac epigenetic repression and regulates transcriptional susceptibility via H3K9 methylation.

Journal of Molecular and Cellular Cardiology
Daniel FinkeLorenz H Lehmann
September 3, 2021
Open Access

Induced pluripotent stem cells derived cardiomyocytes from Duchenne Muscular Dystrophy patients in vitro.

Pakistan Journal of Medical Sciences
Fareeha Faizan Ghori, Mohsin Wahid
August 30, 2021
Open Access

LATS2 Deletion Attenuates Myocardial Ischemia-Reperfusion Injury by Promoting Mitochondrial Biogenesis.

Oxidative Medicine and Cellular Longevity
Yi ChenHongbing Yan
August 28, 2021

QuinoMit Q10-Fluid attenuates hydrogen peroxide-induced irregular beating in mouse pluripotent stem cell-derived cardiomyocytes.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Filomain NguemoJürgen Hescheler
August 27, 2021
Open Access

Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells.

International Journal of Molecular Sciences
Yong-Jin KimSeung-Yup Ku

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2021 Meta ULC. All rights reserved